ARGX vs RVMD
argenx SE and Revolution Medicines, Inc., both Healthcare
argenx SE is the larger company at $55B against $40B. Over the past year RVMD returned +245% against +3.8% for ARGX. The RyuScore puts ARGX ahead, 11 against 7 out of 100.
| Figure | ARGX | RVMD |
|---|---|---|
| Last close | $882 | $186 |
| Market cap | $55B | $40B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 45.1 | n/a |
| 1-year return | +3.8% | +245% |
| 5-year return | +199% | +570% |
| RyuScoresector-relative, 1–10 | 11/100 | 7/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
argenx SE
Revenue of $2.5B in H2 2025, net income $877M.
Revolution Medicines, Inc.
Open these two in the interactive comparison to add more names, change the period or see the correlation.